MedPath

Tiny Robots Thinner Than a Human Hair Could Help Fight Cancer Tumours, Reveals Study

A groundbreaking study reveals that tiny robots, thinner than a human hair, have been developed to directly deliver drugs to cancer cells, showing promising results in shrinking bladder tumours in mice and aiming for future human trials.

Scientists have developed special 3D-printed microbots, only 30 microns in diameter, capable of directly delivering drugs to cancer cells. These microbots can easily transition from solid to liquid and back, survive stomach acid, and are designed to pass out of the body in urine. Initial trials in mice have demonstrated their effectiveness in reducing the size of bladder tumours. Researcher Wei Gao from Caltech University highlighted the potential of these microbots for targeted drug delivery and precision surgery, expressing hope for future human trials. This innovative approach aims to enhance the efficiency and control of drug delivery to tumour sites, offering a promising platform for treating various conditions with different therapeutic agents.
Subscribe Icon

Stay Updated with Our Daily Newsletter

Get the latest pharmaceutical insights, research highlights, and industry updates delivered to your inbox every day.

Related Topics

Innovative Approach to Cancer Treatment: Targeted Protein Degradation

A groundbreaking study by Fred Hutch Cancer Center introduces a novel cancer treatment method, targeted protein degradation, which tricks cells into destroying cancer-causing proteins. This approach, currently in clinical trials, has shown promising results in reducing tumor growth and improving survival rates in mice with lung and pancreas tumors caused by the KRAS G12V mutation.

Precision Cancer Therapy Targets KRAS to Eliminate Tumors and Side Effects in Mice

Researchers have developed a targeted cancer therapy that combines a drug, a targeting antibody, and a radioactive payload to precisely destroy tumors.
The therapy targets the KRAS protein, which drives uncontrolled cell growth in many cancers, and marks cancer cells for targeted radiation.

Genetically Engineered Salmonella Shows Promise in Bowel Cancer Treatment

Researchers have genetically engineered *Salmonella* to target and combat bowel cancer cells, potentially turning a disease-causing bacterium into a therapeutic agent.
The engineered *Salmonella* strains elicited an immune response in mice with bowel cancer, allowing their immune systems to remain functional during treatment.

Red Blood Cell-Derived Nanocarriers Deliver Targeted Therapy for Drug-Resistant Lung Cancer

Researchers have repurposed red blood cell-derived extracellular vesicles (EVs) as nanocarriers to deliver antisense oligonucleotides (ASOs) to lung cancer cells.
The ASO-loaded EVs are engineered to target mutant Epidermal Growth Factor Receptors (EGFRs), a common driver of lung cancer, particularly in Asian populations.

Engineered Gut Bacteria Boost Immunotherapy Efficacy in Mouse Models

Dana-Farber researchers engineered harmless gut bacteria to deliver immune-stimulating payloads directly to tumors, enhancing anti-tumor activity.
In mouse models, bacteria carrying modified IL-18 exhibited potent tumor-killing effects, leading to tumor-free status in 30-60% of treated animals.

Graphene-Based Brain Chip Enters Clinical Trials for Enhanced Brain Tumor Surgery

A novel graphene-based brain chip is undergoing its first clinical trial in the UK, potentially revolutionizing brain tumor surgery by precisely differentiating between cancerous and healthy cells.
The brain-computer interface (BCI) device detects a broader range of electrical signals, including previously undetectable high and low frequencies, to improve surgical accuracy.

Implantable Microparticles Deliver Dual Cancer Therapy, Eradicating Tumors in Mice

Researchers have developed implantable microparticles that deliver both heat and chemotherapy directly to tumor sites, enhancing treatment efficacy.
In a mouse model of triple-negative breast cancer, the dual therapy eradicated tumors and significantly prolonged survival compared to single therapies.

Nanoparticle Therapy Shows Promise in Shrinking Pancreatic Tumors in Mice

Researchers at UMass Chan Medical School have developed a nanoparticle therapy that effectively shrinks pancreatic tumors in mice, offering a potential new approach for this deadly cancer.
In preclinical trials, the nanoparticle treatment led to significant tumor reduction in eight out of ten mice, with two mice remaining tumor-free for an extended period.

Antidepressant Vortioxetine Shows Promise in Treating Glioblastoma in Preclinical Studies

Researchers have identified vortioxetine, an FDA-approved antidepressant, as a potential treatment for glioblastoma, an aggressive brain tumor, due to its ability to cross the blood-brain barrier.
Preclinical studies in cell cultures and mice demonstrated that vortioxetine effectively suppressed glioblastoma cell growth, especially when combined with standard treatments like chemotherapy and radiation.

Swimming Microrobots Deliver Cancer-fighting Drugs to Metastatic Lung Tumors in Mice

Engineers at UC San Diego have developed microrobots that swim through the lungs to deliver cancer-fighting drugs directly to metastatic tumors in mice, showing promise in inhibiting tumor growth and spread, and boosting survival rates.

Reference News

[1]
Tiny robots thinner than a human hair could help fight cancer tumours, reveals study
thesun.co.uk · Dec 15, 2024

Scientists developed 3D-printed microbots, thinner than a human hair, capable of delivering drugs directly to cancer cel...

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy